000			01324 a2200373 4500
005			20250512114122.0
264		0	_c19730810
008			197308s 0 0 eng d
022			_a0026-556X
040			_aNLM _beng _cNLM
100	1		_aTolosa, E
245	0	0	_aParkinson's disease; modern treatment. _h[electronic resource]
260			_bMinnesota medicine _cJun 1973
300			_a497-502 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAmantadine _xtherapeutic use
650	0	4	_aAmphetamine _xtherapeutic use
650	0	4	_aAntidepressive Agents _xtherapeutic use
650	0	4	_aAntiparkinson Agents _xtherapeutic use
650	0	4	_aAromatic Amino Acid Decarboxylase Inhibitors
650	0	4	_aCatechol O-Methyltransferase Inhibitors
650	0	4	_aDesipramine _xtherapeutic use
650	0	4	_aDihydroxyphenylalanine _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Combinations
650	0	4	_aDrug Incompatibility
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aImipramine _xtherapeutic use
650	0	4	_aMonoamine Oxidase Inhibitors _xtherapeutic use
650	0	4	_aParasympatholytics _xtherapeutic use
650	0	4	_aParkinson Disease _xdrug therapy
773	0		_tMinnesota medicine _gvol. 56 _gno. 6 _gp. 497-502
999			_c4580000 _d4580000